date:Sep 19, 2012
ay be useful as an anti-cancer therapeutic adjunct or preventive agent, especially for CS patients harboring SDH mutations, and its protective properties should be further explored, said Eng.
CS predisposes individuals to several types of cancers an 85 percent lifetime risk of breast cancer, a 35 percent risk for epithelial thyroid cancer, and increased risk of other cancers as well.
Approximately one in 200,000 people are affected by CS.